Whats driving it
Sodium-glucose cotransporter 2 (SGLT2) inhibitors or GLP-1 RAs are recommended as second-line treatment, and pioglitazone, DPP4 inhibitors, acarbose, or insulin as third-line treatment [5]
In 2023, the FDA updated its safety label for GLP-1 receptor agonists like Ozempic to include warnings about potential gastrointestinal risks
You may find that your food noise returns, your appetite increases, and your weight loss plateaus
Injection Dates and Notes A GLP-1 injection tracker can be helpful when you want to remember injection dates, weekly timing, and notes you may want to discuss later
Noom operates primarily as a behavioral-change platform that integrates medication options, while Hims functions as a direct-to-consumer telehealth provider offering multiple GLP-1 medications alongside consultations